Coventry Enterprises LLC v. Sanomedics International Holdings, Inc.

191 F. Supp. 3d 312, 2016 U.S. Dist. LEXIS 74733, 2016 WL 3223625
CourtDistrict Court, S.D. New York
DecidedJune 8, 2016
Docket14 Civ. 8727 (NRB)
StatusPublished
Cited by2 cases

This text of 191 F. Supp. 3d 312 (Coventry Enterprises LLC v. Sanomedics International Holdings, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Coventry Enterprises LLC v. Sanomedics International Holdings, Inc., 191 F. Supp. 3d 312, 2016 U.S. Dist. LEXIS 74733, 2016 WL 3223625 (S.D.N.Y. 2016).

Opinion

MEMORANDUM AND ORDER

NAOMI REICE BUCHWALD, UNITED STATES DISTRICT JUDGE

In this breach of contract action, plaintiff contends that defendants breached an agreement for the sale of certain convertible securities. Plaintiff now moves for summary judgment, seeking rulings that defendants are liable for breach of contract and that the breach caused plaintiff damages arising from the lost opportunity to convert the withheld securities into stock to be resold at a profit. For the following reasons, we conclude that defendants are liable for breach of contract but that damages are inappropriate to resolve at this time. Accordingly, plaintiffs motion for summary judgment is granted in part and denied in part.

I. BACKGROUND1

This case arises from an agreement for the purchase of convertible debt securities. The parties to the transaction, and to this case, are the issuer of the securities, defendant Sanomedics International Holdings, Inc. (“Sanomedics” or “SIMH”);2 the seller, defendant CLSS Holdings, LLC (“CLSS”); and the purchaser, plaintiff Coventry Enterprises LLC (“Coventry”).3

[315]*315On September 10, 2014,4 defendants agreed to a “Memorandum of Terms” under which Coventry would purchase from CLSS $145,000 in principal, plus accrued interest, of a promissory note that had previously been issued to CLSS by Sa-nomedics. Coventry 56.1 ¶¶ 3-4; see Boden-stein Decl. Ex. 1. This pre-existing note was convertible into Sanomedics stock pursuant to an associated note certificate. See Bodenstein Decl. Ex. 3 (“Note Certificate”).5

On September 11, the parties entered into a “Debt Purchase Agreement” memorializing the terms of the sale to Coventry. See Bodenstein Decl. Ex. 2 (the “DPA”). CLSS agreed to sell the “Transferred Rights” to Coventry, defined as “all rights with respect to the $145,000.00 in principal under that promissory note ... issued by Sanomedics.” DPA ¶ 1. Sanomedics also executed the DPA, agreeing to “treat Buyer [Coventry] as party to, and having all the rights of the Seller [CLSS] with respect to the Transferred Rights.” DPA ¶ 4.5(h). By its terms, the DPA is an integrated agreement to be governed by New York law. DPA ¶¶ 6.3, 6.7.

The transaction, as described in both the Memorandum of Terms and the subsequent DPA, was to take place in three “closings,” with the second to take place within thirty days of the first, and the third to take place within thirty days of the second. See DPA ¶ 3. Specifically, Paragraph 3 of the DPA describes the closing process as follows:

The closing of the transactions contemplated by this Agreement (the “Closing”) shall take place in three separate closings. At the first closing, which shall occur upon the mutual execution of this Agreement, the Buyer [Coventry] shall purchase from the Seller [CLSS] $50,000 of the Assigned Portion [of the Sa-nomedics promissory note] and shall pay to the Seller the sum of[]$50,000 less $1,000 in legal fees. At the second closing, which shall occur within 30 days of the first closing, and subject to market conditions, the Buyer shall purchase from the Seller another $50,000 of the Assigned Portion less $1K in legal fees'. At the third closing, - which shall occur within 30 days of the second closing, and subject to market conditions, the Buyer shall purchase from the Seller another $45,000 of the Assigned Portion less $1K in legal fees.

DPA ¶ 3.

The first closing took place on September 11: Coventry paid CLSS, and, that same day, Sanomedics informed its transfer agent, and the transfer agent acknowledged, that Coventry was to be issued a replacement note for $50,000. Coventry 56.1 ¶ 8. Coventry took possession of this note. Defs. 56.1 ¶ 6.

Thirty days from the first closing date of September 11 was October 11. October 11 was a Saturday; October 12 was a Sunday; and Monday, October 13, was the Columbus Day holiday. Coventry 56.1 ¶ 13.

Between October 10 and October 13, the market price of Sanomedics stock increased, precipitously.6 Coventry 56.1 ¶27. [316]*316As a result, the holder of the> Sanomedics convertible note stood to make a substantial profit- by converting the note to Sa-nomedics shares and selling the conversion shares to the public. Id. ¶¶ 31-32.

On October 14, Coventry wired $49,000 to CLSS in an attempt to consummate the second closing. Defs. 56.1 ¶ 9. However, CLSS refused to consummate the second closing. On October 15, at 11:43 AM, Craig Sizer wrote in an email to Jack Boden-stein, co-rowner of Coventry, that “in light of several factors we are deciding not to move forward with the sale of the remaining balance of the note referenced in our original agreement.” Bodenstein Deck Ex. 12, at 1-2.

Bodenstein sought recourse from Sa-nomedics, writing at 12:32 PM to Sa-nomedics CFO David Langle that “I do not understand why you are not sending back the replacement note.... You signéd the Debt [Pjurchase Agreement, and now you have to honor it. I am sending you a conversion notice for 1,684,210 shares for $16,000 of the note.” Bodenstein Decl. Ex. U.

In the meantime, Bodenstein had responded to Sizer to insist that the parties’ agreement-entitled him to the next note. At 1:41 ,PM, Sizer replied, “[y]ou are outside the 30 day window and the note has already been converted.” Bodenstein Deck Ex. 12, at 1.

Finally, Bodenstein emailed Sanomedics President Keith Houlihan, who responded at 4:20 PM that “CLSS- has informed us that they have issue with this matter and are not selling the note. Please address this with their team as it’s a CLSS and Coventry concern not Sanomedics.” Bo-denstein Deck Ex. 10, at 1.

On October 15, plaintiff, through counsel, sent defendants a demand letter alleging that defendants had breached the DPA. Bodenstein Deck Ex. 13. Ultimately, CLSS returned Coventry’s $49,000 payment for the attempted second closing, and Coventry would never wire to CLSS the final $44,000 contemplated by the DPA with respect to the third closing. Defs. 56.1 ¶¶ 10-11.

On November 3, Coventry filed its complaint in this Court. On February 5, 2015, defendants moved to dismiss the Complaint for failure to. state a claim upon which relief can be granted. Defendants contended they were not bound to consummate the second closing because (1) Coventry’s October 14 payment was not “within 30 days of the first closing” and therefore untimely under the DPA; and (2) the phrase “subject to market conditions” in the DPA’s third paragraph rendered the parts of the DPA pertaining to the second and third closings illusory and unenforceable. By Memorandum and Order dated July 23, 2015, we denied the motion, rejecting both of defendants’ arguments. See ECF No. 19 (“July 23 M&O”). Defendants answered the complaint on August 11, 2015. .

Coventry now moves for summary judgment. ECF No. 26. Coventry argues defendants breached the DPA and are liable for damages in the amount of at least $525,328, but perhaps as much as $1,278,000, based on Coventry’s hypothetical analyses of the proceeds it would have earned had it been delivered the remaining $95,000 of the convertible note, converted [317]*317it to stock, and sold the conversion shares at prevailing market prices. See Boden-stein Deck Ex. 7; Pl.’s Reply to Defs.’ Opp’n to Mot. for Summ. J. at 15.

II. DISCUSSION

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
191 F. Supp. 3d 312, 2016 U.S. Dist. LEXIS 74733, 2016 WL 3223625, Counsel Stack Legal Research, https://law.counselstack.com/opinion/coventry-enterprises-llc-v-sanomedics-international-holdings-inc-nysd-2016.